We are offering COVID-19 vaccines to current patients. Patients can schedule a vaccination through NYU Langone Health MyChart or the NYU Langone Health app. Learn more about the COVID-19 vaccine.

If you need help accessing our website, call 855-698-9991
Skip to main content
Our Approach to Treating

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy is an inherited condition that causes thickening of the walls of the left ventricle, the main pumping chamber of the heart. In some people, the heart becomes stiff and cannot fill properly or pump enough blood to provide an adequate supply to the body, particularly during exercise. In others, blood flow from the heart is obstructed. This condition may be associated with irregular heart rhythms.

Cardiologists and heart surgeons at NYU Langone’s Hypertrophic Cardiomyopathy Program have 25 years of experience managing this condition. Our doctors work with specialists from our Heart Rhythm Center—including electrophysiologists, who specialize in heart rhythm disorders, and cardiac device management doctors—to care for people with the condition. Our experts also provide genetic counseling and testing for family members of people diagnosed with hypertrophic cardiomyopathy.

Our Hypertrophic Cardiomyopathy Program is one of two programs in New York State accredited as a Center of Excellence by the Hypertrophic Cardiomyopathy Association.

Treatment for Hypertrophic Cardiomyopathy

Treatment may include lifestyle changes, medication, implanted cardiac devices, or cardiac surgery, known as septal myectomy.

Our Research and Education in Hypertrophic Cardiomyopathy

Learn more about our research and professional education opportunities.